Report cover image

Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 8th Edition

Publisher Kalorama Information
Published Mar 20, 2018
Length 324 Pages
SKU # KLI15622501

Description

Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 8th Edition

In eight editions, Kalorama Information's report, Outsourcing in Drug Discovery, has kept the industry informed, providing answers to these questions and more. The 8th edition contains 2017 market size estimates and 2022 forecasts for 21 different parts of the process that might be outsourced, including:
  • Chemistry Services Market, 2017-2022
  • Building Blocks Outsourcing Market, 2017-2022
  • Compound Synthesis Market, 2017-2022
  • Library Construction Market, 2017-2022
  • Process Research Market, 2017-2022
  • Biology Services Market, 2017-2022
  • Protein Expression Market, 2017-2022
  • Structural Analysis Market, 2017-2022
  • Target Validation Market, 2017-2022
  • Pathways Analysis Market, 2017-2022
  • Screening Services Market, 2017-2022
  • Assay Development Market, 2017-2022
  • Primary Screening Market, 2017-2022
  • Secondary Screening Market, 2017-2022
  • Lead Optimization Market, 2017-2022
  • Early ADMET Market, 2017-2022
  • Analogues Creation Market, 2017-2022
  • Computational Support Market, 2017-2022
  • Other Services Market, 2017-2022
The drug discovery process is long, arduous and costly, which has driven outsourcing in this field. The first phase is discovery of a lead compound, a molecule that affects biological function by binding to a target protein or nucleic acid in a way that is useful for treatment of disease. The process by which molecules are identified for their therapeutic value involves synthesis and analysis of many derivatives of the original leads. There are several steps in the drug discovery process including hit confirmation, lead generation, lead optimization, and other studies. Drug discovery is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will actually yield products that achieve regulatory approval by the Food & Drug Administration (FDA).

Since the last edition of Kalorama's report on the outsourcing of discovery of novel compounds in the pharmaceutical industry, the industry has seen dramatic change. Pharmaceutical companies facing cutbacks in R&D budgets and new demands for novel products need to outsource aspects of their operations. Core functions once kept in-house such as the discovery of potential new drugs are now commonly outsourced.

Table of Contents

324 Pages
    • Overview
    • Scope and Methodology
    • Introduction
    • The Drug Discovery Process
    • Outsourcing to Increase Efficiency
    • Outsourcing Drug Discovery
    • Contract Research Organizations
    • Offshoring Contract Drug Discovery
    • Outsourcing to China
    • Outsourcing to India
    • Outsourcing to Eastern Europe
    • Drug Discovery Outsourcing Market
    • Background
    • Outsourcing Drug Discovery
    • The Outsourcing Decision
    • Factors to Consider in Offshore Outsourcing
    • Selecting a Contract Research Organization
    • Global Outsourcing
    • Introduction
    • Accelerating the Drug Discovery Process
    • Outsourcing to Increase Efficiency
    • Outsourcing to Access Novel Technologies
    • Overview
    • Outsourcing Drug Discovery Useful Core Management Tool
    • Contract Research Organizations
    • Outsourcing Contract Drug Discovery Offshore
    • Outsourcing to China
    • Outsourcing to India
    • Outsourcing to Eastern Europe
    • Overview
    • Drug Discovery Outsourcing Market
    • Market Analysis by Segment
    • Contract Drug Discovery Competitors
    • The Evolving Open-Innovation Model Gaining Traction in Drug Discovery
    • Market Growth Expanding Global Reach and Scale of Drug Discovery Services
    • Is Artificial Intelligence (AI) the Future of Drug Discovery?
    • Albany Molecular Research, Inc.
    • Aptuit, a Division of Evotec AG
    • Asclepia MedChem Solutions
    • Asinex Ltd.
    • AsisChem Inc.
    • Aurelia Bioscience Ltd
    • Axxam SpA
    • BioDuro
    • Charles River Laboratories, Inc.
    • Charnwood Molecular
    • ChemBridge Corp.
    • Chemical Diversity Inc. (ChemDiv)
    • ChemPartner Co., Ltd., subsidiary of ShangPharma
    • Covance Inc. (Laboratory Corporation of America)
    • CreaGen Biosciences, Inc.
    • Crown Bioscience
    • Cyprotex PLC, an Evotec AG Company
    • Domainex
    • Enamine Ltd.
    • Evotec AG
    • Exelgen Discovery
    • GVK Biosciences Private Limited (GVK Bio)
    • GenScript USA Inc.
    • Graffinity Pharmaceuticals GmbH (subsidiary of NovAliX S.A.S)
    • HitGen Ltd.
    • Hutchison MediPharma, Ltd.
    • Jubilant Biosys Ltd. (JBL), a subsidiary of Jubilant Life Sciences Ltd.
    • Nanosyn, Inc.
    • Olon Ricerca Biosciences
    • Pharmaron, Inc.
    • Selcia Limited
    • Selvita S.A.
    • Shanghai Medicilon, Inc.
    • Sundia MediTech Company, Ltd.
    • Sygnature Discovery Limited
    • TCG Lifesciences Pvt Ltd.
    • Viva Biotech, Ltd.
    • WuXi AppTec Co. Ltd.
    • Company Names and Addresses

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us